Alnylam Pharmaceuticals, Inc.

DUL.DE·XETRA·Healthcare
Compare
144.85+2.85 (+2.01%)today
As of Nov 4, 1:17 PM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close142.00
Open141.80
Day range141.80144.85
52-week range141.35407.50
Off day high0.00%
Off 52-week high−64.45%
Volume333
Avg. volume (3M)63.00
Market cap19.40B
EPS (TTM)17.04
Forward P/E—
P/E ratio (TTM)8.50
Dividend yield—
Beta (5Y)0.27
Shares outstanding133.94M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin52.85%

Against its peers

Compare in full ›
DUL.DE IONS ARWR BBIO ROIV 4591.T
Market cap 19.40B 6.67B 8.71B 15.17B 27.61B 3.39B
P/E (TTM) 8.5 — — — — —
Forward P/E — -35.0 -12.4 -225.0 -27.5 -1.1
Price/book 6.0 15.1 18.7 -5.9 6.5 1.2
Dividend yield — — — — — —
1-year change −37.50% −45.82% +55.68% +24.17% +85.85% −29.21%
Today +2.01% −0.67% +3.56% +5.21% +6.08% −4.76%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All DUL.DE news ›

From the 4Search news index, newest first.

In the news

18mentions in 30 days
18with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance